COVID-19 in Patıents Wıth Behcet's Dısease: Outcomes and Rate of Behçet's Exacerbatıons ın a Retrospectıve Cohort

B Polat, A Erden, SC Güven, B Armağan… - Modern …, 2021 - ncbi.nlm.nih.gov
Objectives Aim of this study is to investigate the outcomes of coronavirus disease 2019
(COVID-19) in our cohort of Behçet's disease (BD) patients in means of mortality, admission …

[HTML][HTML] The Clinical Outcomes of COVID-19 in Patients with Behçet's Disease: A Series of 7 Cases and Brief Review of the Literature

K Nas, G Dilek, MK Unan, İ Tekeoğlu… - The Eurasian Journal of …, 2022 - ncbi.nlm.nih.gov
Conventional debates surrounding the treatment of coronavirus disease 2019 still continue
in the literature. Colchicine is one of the recommended agents in the treatment of …

[HTML][HTML] COVID-19 among patients with Behçet syndrome in the United States

H Pakhchanian, R Raiker, S Kardeş - Clinical Rheumatology, 2022 - Springer
Dear Editor, Behçet syndrome is a chronic multisystem condition that is characterized by
relapsing–remitting periods of a diverse spectrum of manifestations [1]. Although it is more …

Fatal Case of Burkholderia gladioli Pneumonia in a Patient With COVID-19

S Rajendraprasad, ZA Creech, GTD Truong… - Ochsner …, 2022 - ochsnerjournal.org
Background: Burkholderia gladioli (B gladioli) is a rare, gram-negative rod that was initially
regarded as a plant pathogen. However, B gladioli has been reported as the primary …

Management of patients with Behcet's disease during the COVID‐19 pandemic

R Dursun, SA Temiz, I Özer, M Daye… - Dermatologic …, 2020 - Wiley Online Library
Behçet's disease is a disease characterized by chronic inflammatory vasculitis. In the clinical
symptoms of Behçet's disease, many immunosuppressive and immunomodulatory drugs are …

Erythema nodosum in Behçet's disease in remission: Think COVID-19?

G El Hasbani, ASM Jawad… - SAGE Open Medical …, 2023 - journals.sagepub.com
The coronavirus disease has several manifestations related to the activation of the immune
system. Because of such activation, autoimmune diseases, including vasculitis, have been …

[PDF][PDF] COVID-19 and Basedow disease.

MC Dumitrascu, M Popescu… - … Romana de de …, 2021 - pdfs.semanticscholar.org
ABSTRACT Coronavirus disease-2019 (COVID-19) heavily hits the human body through
various and dramatic ways, and endocrine system is not an exception. Our purpose is to …

[PDF][PDF] Clinical course of COVID-19 infections in patients with Behçet's disease in The Netherlands

AAS den Otter, TB van der Houwen, PM van Hagen… - Clin Exp …, 2022 - pure.eur.nl
Clinical course of COVID-19 infections in patients with Behçet’s disease in The Netherlands
Page 1 Clinical and Experimental Rheumatology 2022 Clinical and Experimental Rheumatology …

[HTML][HTML] Case report: a fatal case of latent melioidosis activated by COVID-19

U Gulati, AC Nanduri, P Juneja… - The American Journal …, 2022 - ncbi.nlm.nih.gov
Melioidosis, endemic in Southeast Asia and Northern Australia, is an uncommon but
frequently fatal opportunistic infection caused by the Gram-negative saprophyte …

[HTML][HTML] Exacerbation of Behcet's Disease and Pyoderma Gangrenosum Following COVID-19 Infection: A Case Report

LFÁ Pérez, S Vila - Cureus, 2023 - ncbi.nlm.nih.gov
Behcet's disease (BD) and pyoderma gangrenosum (PG) are rare autoimmune inflammatory
diseases that have been reported to relapse following COVID-19 infection. BD is a …